SPAC13G6.15c Antibody

What is the predicted function of SPAC13G6.15c in S. pombe and how does this inform antibody selection?

SPAC13G6.15c belongs to a family of proteins potentially involved in cell wall organization in S. pombe. Based on genomic analysis of related fission yeast proteins, SPAC13G6.15c may participate in cell wall matrix assembly or modification, potentially related to glucan synthesis pathways . Antibody selection should account for potential structural similarities with other cell wall-associated proteins such as those in the glucan synthase families. When selecting an antibody, consider that SPAC13G6.15c might share sequence homology with proteins like Sup11p, which shows significant homology to S. cerevisiae Kre9 involved in β-1,6-glucan synthesis .

For optimal antibody selection:

• Target unique epitopes that distinguish SPAC13G6.15c from related proteins

• Consider antibodies raised against synthetic peptides from non-conserved regions

• Validate specificity against knockout controls if available

What extraction methods are optimal for SPAC13G6.15c detection in Western blot experiments?

Extracting SPAC13G6.15c from the complex cell wall matrix of S. pombe requires specialized approaches:

• Spheroplasting Protocol:

  • Digest cell walls with Zymolyase (1.2 mg/ml) in buffer containing 1.2 M sorbitol

  • Incubate at 30°C for 30-45 minutes with gentle agitation

  • Monitor spheroplast formation microscopically

  • Collect spheroplasts by centrifugation at 3000g for 5 minutes

• Protein Extraction Buffer:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 5 mM EDTA

  • 10% glycerol

  • 1% Triton X-100

  • Protease inhibitor cocktail

  • 1 mM PMSF added fresh

For membrane-associated proteins in S. pombe, spheroplasting methods similar to those used for studying Sup11p are recommended, as they effectively release cell wall-associated proteins while preserving their native conformation .

How should I optimize immunostaining protocols for SPAC13G6.15c localization studies?

Based on protocols developed for similar S. pombe cell wall proteins:

Optimized Immunostaining Protocol:

• Fixation Options:

  • Methanol fixation (-20°C, 6 minutes) for preserving antigen recognition

  • Alternatively, 3.7% formaldehyde, 10-15 minutes at room temperature

• Permeabilization:

  • 1% Triton X-100 for 2 minutes

  • Or enzymatic digestion with 0.5 mg/ml Zymolyase in phosphate buffer

• Blocking:

  • 5% BSA, 0.1% Tween-20 in PBS for 60 minutes

  • Consider adding 5% normal serum from the secondary antibody host species

• Antibody Dilutions and Incubation:

  • Primary: 1:100-1:500 range (optimize empirically)

  • Secondary: 1:500-1:2000 fluorophore-conjugated antibodies

  • Primary: overnight at 4°C

  • Secondary: 2 hours at room temperature

• Controls:

  • Include peptide competition controls

  • Secondary-only controls to assess background

  • Wild-type vs. SPAC13G6.15c deletion strains if available

What approaches are most effective for studying potential interacting partners of SPAC13G6.15c?

To investigate protein-protein interactions of SPAC13G6.15c:

Co-Immunoprecipitation Strategy:

• Tagging Considerations:

  • C- or N-terminal tagging may affect protein function differently

  • HA or GFP tags are commonly used for S. pombe proteins with success in similar studies

• Crosslinking Protocol:

  • Use DSP (dithiobis[succinimidylpropionate]) at 2 mM final concentration

  • Incubate cells for 30 minutes at room temperature

  • Quench with 20 mM Tris-HCl pH 7.5 for 15 minutes

• Extraction Buffer Optimization:

  • For membrane proteins: 1% digitonin or 0.5% NP-40

  • Include 150-300 mM NaCl to reduce non-specific interactions

  • Add 10% glycerol for protein stability

• Validation Methods:

  • Reciprocal co-IP with antibodies against suspected partners

  • Mass spectrometry analysis of immunoprecipitated complexes

  • Yeast two-hybrid as complementary approach

When investigating potential interactions with cell wall synthesis machinery, consider the septum formation pathway and glucan synthesis components as described in studies of related proteins .

How can I differentiate between specific and non-specific binding when using SPAC13G6.15c antibodies?

Ensuring antibody specificity requires rigorous validation:

Validation Framework:

• Peptide Competition Assay:

  • Pre-incubate antibody with 5-10 μg/ml of immunizing peptide

  • Run in parallel with standard antibody conditions

  • Specific signals should be abolished or significantly reduced

• Knockout/Knockdown Controls:

  • If SPAC13G6.15c is essential (like sup11+), use repressible promoter systems (nmt81)

  • Compare antibody signal between wild-type and depleted conditions

• Cross-Reactivity Assessment:

  • Test antibody against recombinant SPAC13G6.15c

  • Perform Western blot against whole cell lysates from species lacking SPAC13G6.15c homologs

• Epitope Mapping:

  • Use truncated recombinant proteins to identify the specific binding region

  • Confirm epitope availability in native protein conformations

Implementing this validation framework is crucial, especially considering the challenges in antibody specificity reported for other S. pombe cell wall proteins .

What mass spectrometry approaches are most effective for studying post-translational modifications of SPAC13G6.15c?

Based on studies of similar S. pombe proteins:

MS Protocol for PTM Analysis:

• Sample Preparation:

  • Immunoprecipitate SPAC13G6.15c using validated antibodies

  • Perform in-gel or in-solution tryptic digestion

  • Consider enrichment strategies for specific modifications:

    • Phosphopeptides: TiO₂ or IMAC columns

    • Glycopeptides: Lectin affinity or hydrazide chemistry

• MS Instrumentation and Settings:

  • High-resolution MS/MS (Orbitrap or Q-TOF)

  • HCD and ETD fragmentation methods

  • Include neutral loss scans for phosphorylation (−98 Da)

• Data Analysis Strategy:

  • Search against S. pombe database with PTM variable modifications

  • Manual validation of PTM site assignments

  • Consider sequential enrichment for multiple modification types

• Glycosylation Analysis:

  • EndoH treatment to assess N-glycosylation status

  • PNGase F with ¹⁸O-water to confirm N-glycosylation sites

  • Compare glycosylation patterns in wild-type vs. O-mannosylation mutants

Since similar S. pombe proteins show complex patterns of O-mannosylation and potential N-glycosylation on unusual N-X-A sequons, special attention should be paid to these modifications .

How can I address inconsistent SPAC13G6.15c detection in Western blot experiments?

Troubleshooting inconsistent Western blot results:

Systematic Troubleshooting Approach:

• Sample Preparation Optimization:

  • Ensure complete cell lysis using glass beads beating (5 cycles, 30 seconds each)

  • Add 1% deoxycholate to extraction buffer for membrane proteins

  • Maintain sample at 4°C throughout preparation

  • Include phosphatase inhibitors (10 mM NaF, 2 mM Na₃VO₄)

• Transfer Conditions:

  • Use PVDF membranes for higher protein binding capacity

  • Optimize transfer time (1-2 hours) and voltage (25-30V overnight)

  • Consider specialized transfer buffers for glycoproteins:

    • Add 0.1% SDS for high molecular weight proteins

    • Include 20% methanol for smaller proteins

• Detection Enhancement:

  • Signal amplification using TSA (tyramide signal amplification)

  • Extend primary antibody incubation (overnight at 4°C)

  • Test different blocking agents (5% milk vs. 5% BSA)

• Technical Considerations:

  • Freshly prepare all buffers and solutions

  • Include positive control samples in each experiment

  • Consider dot blot analysis to assess antibody functionality

What approach should I take when Western blot and immunofluorescence data for SPAC13G6.15c subcellular localization are contradictory?

When facing contradictory localization data:

Reconciliation Strategy:

• Epitope Accessibility Assessment:

  • Different fixation methods expose different epitopes

  • Try multiple antibodies targeting different regions of SPAC13G6.15c

  • Compare native protein vs. tagged versions (N- and C-terminal tags)

• Subcellular Fractionation:

  • Perform sucrose density gradient centrifugation to separate cellular compartments

  • Analyze fractions by Western blot with compartment-specific markers:

    • ER: BiP/Grp78

    • Golgi: Anp1

    • PM: Pma1

    • Cell wall: Gas2p

• Multi-method Confirmation:

  Method	Advantages	Limitations
  Immunogold-EM	High resolution	Complex sample prep
  Live cell imaging	Dynamic information	Requires functional tag
  BiFC	In vivo interaction	Potential artifacts
  Subcellular fractionation	Biochemical validation	Limited spatial resolution

• Dynamic Localization Considerations:

  • Assess localization throughout cell cycle

  • Compare growing tips vs. septum during division

  • Evaluate changes during stress conditions

For yeast cell wall proteins, localization can change drastically during different growth phases and cell cycle stages, as observed with related proteins like Gas1p and Gas2p .

How does SPAC13G6.15c expression and localization change during the cell cycle, and what experimental approaches best capture these dynamics?

Based on patterns observed in related S. pombe proteins:

Cell Cycle Analysis Framework:

• Synchronization Methods:

  • Nitrogen starvation and release

  • Hydroxyurea block (DNA synthesis inhibition)

  • cdc25-22 temperature-sensitive mutant arrest-release

  • Lactose gradient centrifugation for size-based separation

• Time-course Sampling Strategy:

  • Collect samples every 20 minutes for 4-6 hours

  • Process parallel samples for:

    • Protein expression (Western blot)

    • Localization (immunofluorescence)

    • mRNA levels (qRT-PCR)

• Quantification Approaches:

  • Measure fluorescence intensity at cell poles vs. septum

  • Calculate protein abundance normalized to tubulin

  • Determine mRNA expression relative to act1+

• Expected Patterns:

  • Cell wall synthesis proteins often show periodic expression

  • Localization typically shifts between cell poles during interphase and septum during cytokinesis

  • Some proteins show constant expression but changing localization

Similar to Bgs4p, which is synthesized periodically during cell cycle and is crucial during cytokinesis and polarized growth, SPAC13G6.15c may show cell cycle-dependent regulation .

How can I design experiments to investigate the role of SPAC13G6.15c in cell wall integrity and septum formation?

Experimental Design Framework:

• Genetic Manipulation Approaches:

  • CRISPR/Cas9 genome editing for precise modifications

  • Repressible promoter systems (nmt1/41/81) for conditional expression

  • Auxin-inducible degron for rapid protein depletion

• Phenotypic Characterization:

  • Calcofluor white staining to visualize septum formation

  • Transmission electron microscopy to examine cell wall ultrastructure

  • Growth assays with cell wall-perturbing agents:

    • Calcofluor white (chitin/glucan binding)

    • Congo red (β-glucan binding)

    • Zymolyase sensitivity (β-glucan degradation)

• Biochemical Cell Wall Analysis:

  • Alkali-soluble and alkali-insoluble fraction separation

  • Assessment of β-1,3-glucan vs. β-1,6-glucan content

  • Analysis of protein glycosylation patterns

• Interaction Studies:

  • Synthetic genetic array analysis with other cell wall genes

  • Co-immunoprecipitation with known septum formation proteins

  • Multicopy suppressor screens to identify functional relationships

Studies on related proteins show that depletion can lead to severe morphological defects and septum malformation with accumulation of cell wall material, providing a framework for experimental design .

What are the methodological considerations for using SPAC13G6.15c antibodies in chromatin immunoprecipitation (ChIP) experiments?

While SPAC13G6.15c is likely not a transcription factor based on available data, if investigating potential nuclear functions:

Optimized ChIP Protocol for S. pombe:

• Crosslinking Optimization:

  • 1% formaldehyde for 15 minutes at 30°C

  • Quench with 125 mM glycine for 5 minutes

• Chromatin Fragmentation:

  • Sonication: 12-15 cycles (30s ON/30s OFF) at high power

  • Target fragment size: 200-500 bp

  • Verify fragmentation by agarose gel electrophoresis

• Immunoprecipitation Conditions:

  • Pre-clear lysate with Protein A/G beads for 1 hour

  • Incubate with 2-5 μg antibody overnight at 4°C

  • Include IgG control and input samples

• Washing and Elution:

  • Sequential washes with increasing stringency

  • Elute DNA-protein complexes with 1% SDS, 0.1M NaHCO₃ at 65°C

  • Reverse crosslinks at 65°C overnight

• Data Analysis Approach:

  • qPCR for targeted analysis of specific loci

  • ChIP-seq for genome-wide binding profiles

  • Integrate with transcriptome data from similar conditions

How can I use proximity-dependent labeling to identify the SPAC13G6.15c interactome in living cells?

Proximity Labeling Strategy:

• Construct Design:

  • C-terminal BioID2 or TurboID fusion

  • N-terminal APEX2 fusion if C-terminus is functional

  • Maintain native promoter expression levels

  • Include flexible linker (GGGGS)₃ between protein and enzyme

• Labeling Protocol:

  • For BioID/TurboID: 50 μM biotin for 1-3 hours

  • For APEX2: 500 μM biotin-phenol, 1 mM H₂O₂ for 1 minute

  • Quench APEX2 reaction with 10 mM sodium ascorbate, 5 mM Trolox

• Control Experiments:

  • Enzyme-only expression control

  • Catalytically inactive enzyme fusion

  • Differential labeling under varied conditions

• Analysis Pipeline:

  • Streptavidin pulldown of biotinylated proteins

  • MS/MS identification of enriched proteins

  • SAINT or similar algorithm for specificity scoring

  • Validation of key interactions by co-IP or genetic methods

This approach is particularly valuable for membrane and cell wall proteins where conventional IP methods may disrupt native interactions .

What strategies can resolve conflicting data about SPAC13G6.15c function in cell wall organization?

When facing contradictory functional data:

Integrated Analysis Framework:

• Multi-method Phenotypic Analysis:

  • Combine microscopy, biochemical, and genetic approaches

  • Quantitative phenotyping (growth rates, morphology measures)

  • Environmental perturbation tests (temperature, osmotic stress)

• Conditional Mutant Strategy:

  • Create temperature-sensitive alleles

  • Analyze fast-acting degron fusions

  • Use chemical genetics with analog-sensitive mutants

• Epistasis Analysis:

  • Double mutant combinations with known cell wall genes

  • Suppressor screens to identify functional pathways

  • Overexpression studies in mutant backgrounds

• Comparative Analysis Table:

  Approach	Strength	Limitation	Expected Outcome
  Gene deletion	Direct assessment	Lethal if essential	Viability, growth defects
  Depletion	Temporal control	Secondary effects	Progressive phenotype development
  Point mutations	Structure-function	Labor intensive	Domain-specific functions
  Chimeric proteins	Functional domains	Artificial constructs	Complementation patterns

• Integration Strategy:

  • Weight evidence by methodological rigor

  • Consider evolutionary conservation patterns

  • Incorporate data from related species/proteins

Based on studies of related proteins like Sup11p, integrated approaches combining subcellular localization, mutant phenotypes, and biochemical analysis of cell wall composition provide the most comprehensive functional insights .